Skip to content
WELCOME10 — 10% OFF YOUR FIRST ORDER  ·  FREE SHIPPING OVER $300 CAD  ·  COA ON EVERY ORDER

PT-141 (Bremelanotide) Handling Guide: Common Mistakes to Avoid

Most handling advice for research peptides is written generically. The practices below are the ones that specifically matter for PT-141 (Bremelanotide) — including the mistakes it is unusually easy to make with this compound.

Cyclic heptapeptide, melanocortin receptor agonistReproductiveMetabolic

In plain English

Keep it dark at every stage. Ordinary gentle mixing is fine — the rigid ring is not agitation-sensitive the way long flexible chains are. Portion rather than repeatedly opening one vial.

What PT-141 (Bremelanotide) actually is

PT-141 has an unusual history. It is a breakdown product of a compound originally developed for research into skin pigmentation, and an unexpected observation during that work redirected attention to the breakdown product, which was then developed as its own line of research.

Supplied for laboratory research use only — not for human or animal use.

Research-grade PT-141 (Bremelanotide)

Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.

Technical detail below

Bench practices for PT-141 (Bremelanotide)

  • Protect from light at all stages.
  • Standard gentle reconstitution; the constrained ring is not agitation-sensitive in the way flexible long chains are.
  • Store refrigerated and aliquot rather than repeatedly sampling one vial.

The chemistry behind these practices

  • Tryptophan photo-oxidation — the main chemical route for this sequence.
  • Slow hydrolysis over extended solution storage.
  • Adsorptive loss at dilute working concentrations.

Storage summary

LyophilizedSealed at -20 °C, dry and protected from light.
ReconstitutedRefrigerate at 2–8 °C, protected from light on account of the tryptophan residue.
LightProtect from light — tryptophan photo-oxidation applies.

What PT-141 (Bremelanotide) is studied for

Melanocortin receptor pharmacology

Acts at melanocortin receptors, with MC3R and MC4R the subtypes of research interest.

Central rather than peripheral mechanism

Distinguished in the literature by acting centrally, unlike vascular-mechanism compounds in adjacent research areas.

Melanotan II lineage

Its origin as a metabolite of a pigmentation-research compound is central to understanding its development history.

Cyclic constraint

The lactam bridge restricts conformational freedom, a common strategy for improving receptor selectivity.

Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.

More PT-141 (Bremelanotide) reference

Lab Handling reference for other compounds

PT-141 (Bremelanotide) overview PT-141 (Bremelanotide) calculatorPT-141 (Bremelanotide) product details

PT-141 (Bremelanotide) is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.